1. Home
  2. VABK vs ENTA Comparison

VABK vs ENTA Comparison

Compare VABK & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VABK
  • ENTA
  • Stock Information
  • Founded
  • VABK 1998
  • ENTA 1995
  • Country
  • VABK United States
  • ENTA United States
  • Employees
  • VABK N/A
  • ENTA N/A
  • Industry
  • VABK Major Banks
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VABK Finance
  • ENTA Health Care
  • Exchange
  • VABK Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • VABK 201.8M
  • ENTA 164.6M
  • IPO Year
  • VABK N/A
  • ENTA 2013
  • Fundamental
  • Price
  • VABK $38.50
  • ENTA $8.82
  • Analyst Decision
  • VABK
  • ENTA Strong Buy
  • Analyst Count
  • VABK 0
  • ENTA 4
  • Target Price
  • VABK N/A
  • ENTA $22.25
  • AVG Volume (30 Days)
  • VABK 32.3K
  • ENTA 154.8K
  • Earning Date
  • VABK 10-16-2025
  • ENTA 08-11-2025
  • Dividend Yield
  • VABK 3.47%
  • ENTA N/A
  • EPS Growth
  • VABK 14.13
  • ENTA N/A
  • EPS
  • VABK 3.31
  • ENTA N/A
  • Revenue
  • VABK $56,012,000.00
  • ENTA $64,806,000.00
  • Revenue This Year
  • VABK N/A
  • ENTA N/A
  • Revenue Next Year
  • VABK N/A
  • ENTA $1.65
  • P/E Ratio
  • VABK $12.53
  • ENTA N/A
  • Revenue Growth
  • VABK 7.97
  • ENTA N/A
  • 52 Week Low
  • VABK $33.66
  • ENTA $4.09
  • 52 Week High
  • VABK $44.50
  • ENTA $13.37
  • Technical
  • Relative Strength Index (RSI)
  • VABK 46.00
  • ENTA 60.73
  • Support Level
  • VABK $41.13
  • ENTA $8.33
  • Resistance Level
  • VABK $42.94
  • ENTA $9.17
  • Average True Range (ATR)
  • VABK 2.29
  • ENTA 0.45
  • MACD
  • VABK -0.00
  • ENTA 0.05
  • Stochastic Oscillator
  • VABK 13.90
  • ENTA 81.23

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: